| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 13 | |
| #2 | WIPO (World Intellectual Property Organization) | 4 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Enzymes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Dimitrov Dimiter S | 17 |
| #2 | Zhang Mei-Yun | 5 |
| #3 | Xiao Xiaodong | 4 |
| #4 | Zhu Zhongyu | 3 |
| #5 | Chen Weizao | 3 |
| #6 | Zhongyu Zhu | 3 |
| #7 | Pastan Ira H | 1 |
| #8 | Broder Christopher C | 1 |
| #9 | Feng Yang | 1 |
| #10 | Zhao Qi | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2013108636A1 | High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins | |
| US2011020344A1 | Human monoclonal antibodies specific for CD22 | |
| US2006240515A1 | Soluble fragments of the SARS-CoV spike glycoprotein | |
| WO2006044410A2 | A32 monoclonal antibody fusion proteins for use as hiv inhibitors and vaccines |